Compile Data Set for Download or QSAR
Found 95 with Last Name = 'narayan' and Initial = 'c'
TargetOxaloacetate decarboxylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
University of Maryland Biotechnology Institute

LigandPNGBDBM92964(CHEMBL182928 | Oxalate)copy SMILEScopy InChI
Affinity DataKi:  4.30E+4nMAssay Description:Competitive inhibition constant determined for PA4872 catalyzed oxaloacetate decarboxylation.More data for this Ligand-Target Pair
TargetOxaloacetate decarboxylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
University of Maryland Biotechnology Institute

LigandPNGBDBM92965(3,3-Difluoroxaloacetate)copy SMILEScopy InChI
Affinity DataKi:  4.50E+5nMAssay Description:Competitive inhibition constant determined for PA4872 catalyzed oxaloacetate decarboxylation.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20V8BDSPubMed
TargetOxaloacetate decarboxylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
University of Maryland Biotechnology Institute

LigandPNGBDBM92966(Acetopyruvate)copy SMILEScopy InChI
Affinity DataKi:  5.60E+5nMAssay Description:Competitive inhibition constant determined for PA4872 catalyzed oxaloacetate decarboxylation.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20V8BDSPubMed
TargetOxaloacetate decarboxylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
University of Maryland Biotechnology Institute

LigandPNGBDBM92966(Acetopyruvate)copy SMILEScopy InChI
Affinity DataKi:  1.09E+6nMAssay Description:Competitive inhibition constant determined for PA4872 catalyzed oxaloacetate decarboxylation.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20V8BDSPubMed
TargetOxaloacetate decarboxylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
University of Maryland Biotechnology Institute

LigandPNGBDBM92967(Phosphonopyruvate)copy SMILEScopy InChI
Affinity DataKi:  3.00E+6nMAssay Description:Competitive inhibition constant determined for PA4872 catalyzed oxaloacetate decarboxylation.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20V8BDSPubMed
TargetOxaloacetate decarboxylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
University of Maryland Biotechnology Institute

LigandPNGBDBM50273976(2-oxopentanoate | 2-oxovalerate | alpha-ketovalera...)copy SMILEScopy InChI
Affinity DataKi:  3.20E+6nMAssay Description:Competitive inhibition constant determined for PA4872 catalyzed oxaloacetate decarboxylation.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20V8BDSPubMed
TargetOxaloacetate decarboxylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
University of Maryland Biotechnology Institute

LigandPNGBDBM50273976(2-oxopentanoate | 2-oxovalerate | alpha-ketovalera...)copy SMILEScopy InChI
Affinity DataKi:  6.70E+6nMAssay Description:Competitive inhibition constant determined for PA4872 catalyzed oxaloacetate decarboxylation.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20V8BDSPubMed
TargetOxaloacetate decarboxylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
University of Maryland Biotechnology Institute

LigandPNGBDBM50159792(CHEMBL181886 | Natriumpyruvat | Pyruvate | pyruvic...)copy SMILEScopy InChI
Affinity DataKi:  7.20E+6nMAssay Description:Competitive inhibition constant determined for PA4872 catalyzed oxaloacetate decarboxylation.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20V8BDSPubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020412(CHEMBL3289811)copy SMILEScopy InChI
Affinity DataIC50: 780nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020412(CHEMBL3289811)copy SMILEScopy InChI
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50018442(CHEMBL3286436)copy SMILEScopy InChI
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of human ERG by patch clamp electrophysiological analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2416ZM4PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020404(CHEMBL3289803)copy SMILEScopy InChI
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020413(CHEMBL3289807)copy SMILEScopy InChI
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020414(CHEMBL3289797)copy SMILEScopy InChI
Affinity DataIC50: 4.50E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020411(CHEMBL3289813)copy SMILEScopy InChI
Affinity DataIC50: 4.70E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020415(CHEMBL3289806)copy SMILEScopy InChI
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020408(CHEMBL3289805)copy SMILEScopy InChI
Affinity DataIC50: 5.20E+3nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50018290(CHEMBL3290338)copy SMILEScopy InChI
Affinity DataIC50: 5.30E+3nMAssay Description:Inhibition of human ERG by patch clamp electrophysiological analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2416ZM4PubMed
TargetAdenosine receptor A1(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019515(CHEMBL3291062)copy SMILEScopy InChI
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of adenosine A1 receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4XNMPubMed
TargetAdenosine receptor A1(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019516(CHEMBL3291063)copy SMILEScopy InChI
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of adenosine A1 receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4XNMPubMed
TargetAdenosine receptor A1(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019519(CHEMBL3291056)copy SMILEScopy InChI
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of adenosine A1 receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4XNMPubMed
TargetAdenosine receptor A1(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019514(CHEMBL3290772)copy SMILEScopy InChI
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of adenosine A1 receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4XNMPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50018440(CHEMBL3290342)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERG by patch clamp electrophysiological analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2416ZM4PubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020408(CHEMBL3289805)copy SMILEScopy InChI
Affinity DataIC50: 1.02E+4nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020416(CHEMBL3289799)copy SMILEScopy InChI
Affinity DataIC50: 1.03E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020404(CHEMBL3289803)copy SMILEScopy InChI
Affinity DataIC50: 1.05E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50018444(CHEMBL3290345)copy SMILEScopy InChI
Affinity DataIC50: 1.20E+4nMAssay Description:Inhibition of human ERG by patch clamp electrophysiological analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2416ZM4PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020415(CHEMBL3289806)copy SMILEScopy InChI
Affinity DataIC50: 1.22E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020412(CHEMBL3289811)copy SMILEScopy InChI
Affinity DataIC50: 1.25E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50018447(CHEMBL3290347)copy SMILEScopy InChI
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of human ERG by patch clamp electrophysiological analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2416ZM4PubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020415(CHEMBL3289806)copy SMILEScopy InChI
Affinity DataIC50: 1.41E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019515(CHEMBL3291062)copy SMILEScopy InChI
Affinity DataIC50: 1.60E+4nMAssay Description:Inhibition of human ERG by medium-throughput electrophysiologyMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4XNMPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020412(CHEMBL3289811)copy SMILEScopy InChI
Affinity DataIC50: 1.66E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020411(CHEMBL3289813)copy SMILEScopy InChI
Affinity DataIC50: 2.03E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50018288(CHEMBL3290336)copy SMILEScopy InChI
Affinity DataIC50: 2.10E+4nMAssay Description:Inhibition of human ERG by patch clamp electrophysiological analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2416ZM4PubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50019511(CHEMBL3290766)copy SMILEScopy InChI
Affinity DataIC50: 2.19E+4nMAssay Description:Inhibition of mu opioid receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4XNMPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020417(CHEMBL3289794)copy SMILEScopy InChI
Affinity DataIC50: 2.20E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020411(CHEMBL3289813)copy SMILEScopy InChI
Affinity DataIC50: 2.29E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020418(CHEMBL3289798)copy SMILEScopy InChI
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50018407(CHEMBL3290339)copy SMILEScopy InChI
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of human ERG by patch clamp electrophysiological analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2416ZM4PubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020404(CHEMBL3289803)copy SMILEScopy InChI
Affinity DataIC50: 2.63E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020404(CHEMBL3289803)copy SMILEScopy InChI
Affinity DataIC50: 2.79E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020415(CHEMBL3289806)copy SMILEScopy InChI
Affinity DataIC50: 2.79E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020411(CHEMBL3289813)copy SMILEScopy InChI
Affinity DataIC50: 2.83E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020404(CHEMBL3289803)copy SMILEScopy InChI
Affinity DataIC50: 2.94E+4nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020412(CHEMBL3289811)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020415(CHEMBL3289806)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020412(CHEMBL3289811)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020408(CHEMBL3289805)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50020408(CHEMBL3289805)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2X3501CPubMed
Displayed 1 to 50 (of 95 total ) | Next | Last >>
Jump to: